Literature DB >> 32452217

Mitochondrial delivery of microRNA mimic let-7b to NSCLC cells by PAMAM-based nanoparticles.

Niloufar Maghsoudnia1, Reza Baradaran Eftekhari1, Alireza Naderi Sohi2, Parisa Norouzi1, Hamid Akbari1, Mohammad Hossein Ghahremani3, Masoud Soleimani4, Mohsen Amini5, Hamed Samadi6, Farid Abedin Dorkoosh1,7.   

Abstract

Many biological mechanisms including cellular metabolism and cell death are regulated by mitochondria known as powerhouse of the cell. Recently, let-7b, a tumour-suppressor microRNA has been detected in mitochondria of human cells targeting several mitochondrial-encoded respiratory chain genes. Triphenylphosphonium cation (TPP) is one of the major classes of mitochondriotropics that possess the ability of specifically targeting the mitochondria. PAMAM dendrimers are one of the most available agents in gene delivery due to their well-defined and beneficial features such as large density of surface functional groups. Hyaluronic acid (HA), a natural polysaccharide has been demonstrated to have the abilities such as good biocompatibility and targeting CD44 overexpressed receptors on non-small cell lung cancer (NSCLC) cells. In this research, let-7b-PAMAM (G5)-TPP and let-7b-PAMAM (G5)-TPP-HA nano-carriers were designed to deliver let-7b miRNA mimic to NSCLC cells' mitochondria as a novel way of cancer cells inhibition. Nano-carriers were capable of being successfully taken up by A549 cells and localised in mitochondria environment. Let-7b loaded nanoparticles reduced cell viability and induced apoptosis significantly. Expression of genes involved in mitochondrial oxidative function was decreased resulting in nanoparticles effect on mitochondria. Application of mitochondria targeted-miRNA delivery systems could regulate cellular functions to inhibit lung cancer.

Entities:  

Keywords:  PAMAM (G5) dendrimers; hyaluronic acid; microRNA let-7b; mitochondria; triphenylphosphonium

Year:  2020        PMID: 32452217     DOI: 10.1080/1061186X.2020.1774594

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  3 in total

1.  Prediction of binding miRNAs involved with immune genes to the SARS-CoV-2 by using sequence features extraction and One-class SVM.

Authors:  Juan Gutiérrez-Cárdenas; Zenghui Wang
Journal:  Inform Med Unlocked       Date:  2022-05-02

Review 2.  Role of Nano-miRNAs in Diagnostics and Therapeutics.

Authors:  Donatella Coradduzza; Emanuela Bellu; Antonella Congiargiu; Aleksei Pashchenko; Evzen Amler; Alois Necas; Ciriaco Carru; Serenella Medici; Margherita Maioli
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

3.  Effective Antitumor of Orally Intestinal Targeting Penetrating Peptide-Loaded Tyroserleutide/PLGA Nanoparticles in Hepatocellular Carcinoma.

Authors:  Chenjun Ma; Tiantian Wei; Yingying Hua; Zhongjie Wang; Liefeng Zhang
Journal:  Int J Nanomedicine       Date:  2021-07-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.